InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
1
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+21.7%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the full record of transactions filed by Griffin Stephen D., 首席财务官. Director active across 3 companies, notably VSE CORP. Aggregated, 18 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €128k. History available since 9 November 2021. The latest transaction was disclosed on 3 June 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Griffin Stephen D.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
3,769 股@ US$14.410.019% mcap100.0% 占其流量Common StockSEC:0001193125-26-259520:1
12,840 股Common StockSEC:0001193125-26-259520:0
12,200 股@ US$12.28530.052% mcap73.2% 占其流量Common StockSEC:0001193125-26-197887:0
标准退出：2026年7月29日 (T+90)
12,824 股Common StockSEC:0001193125-26-111502:0
12,840 股0Common StockSEC:0001171843-25-003729:0
2,567 股0Common Stock, par value $.05SEC:0000950170-24-040328:0
1,832 股Common StockSEC:0000950170-24-029945:0
233 股@ US$47.115219.7% 占其流量Common Stock, par value $.05SEC:0000950170-24-000248:0
268 股@ US$41.00820.1% 占其流量Common Stock, par value $.05SEC:0000950170-23-031638:0
1,288 股0Common Stock, par value $.05SEC:0000899243-23-010394:0
66 股0Common Stock, par value $.05SEC:0000899243-23-008396:0
141 股@ US$32.31368.5% 占其流量Common Stock, par value $.05SEC:0000899243-23-000223:0
5,000 股0Common Stock, par value $.05SEC:0000899243-22-035549:0
323 股@ US$33.070420.2% 占其流量Common Stock, par value $.05SEC:0000899243-22-025037:0
1,288 股0Common Stock, par value $.05SEC:0001868979-22-000024:0
64 股0Common Stock, par value $.05SEC:0001868979-22-000017:0
204 股@ US$44.0418.7% 占其流量Common Stock, par value $.05SEC:0001831125-22-000001:0
5,000 股0Common Stock, par value $.05SEC:0001868979-21-000001:0
18 条申报中的 18 条
About Griffin Stephen D.
Directeur Financier, Griffin Stephen D. has filed 18 forms in total. Across the 18 most recent filings we track, buys amount to EUR 127785 and sells to EUR 0, between 2021-11-09 and 2026-06-05, with the transaction nature shown as Attribution. The filings listed involve Anika Therapeutics, Inc. and VSE CORP.
